Stekli27

Mark Fuchs

Biotech-focused retail investor | Early-stage, catalyst-driven trades | Tracking FDA, BLA, and clinical milestones | Risk-taker with a long-term vision.

Strategy:
Joined May 2025

Advertisement|Remove ads.

Advertisement|Remove ads.

Advertisement|Remove ads.